CBD Life Sciences Inc. (CBDL) Stock Price & Growth Analysis

Quote Panel

Updated October 16, 2025

1W -10.00 % 1M 125.00 % 3M 80.00 % 1Y -10.00 %

Key Metrics

Market Cap
844637
Shares Outstanding
1.88B
Share in Float
Dividende
0

Earning Date
No Data
Price Target
0.00045
Average Volume
25.46M
Beta
-3603.52

Range
0.0001-0.0022
Industry
Drug Manufacturers - Specialty & Generic
Website
https://lbcbioscienceinc.com
Sector
Healthcare

Quote Panel

Updated October 16, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

10.30x

P/S Ratio

3.52x

P/B Ratio

0.0

Debt/Equity

-905.0%

Net Margin

$-0.0

EPS

How CBDL compares to sector?

P/E Ratio

Fundamentals

Relative Strength

CBDL

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

CBDL

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

N/A

2025-Revenue

N/A

2025-EPS

N/A

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

NA
vs NA

Q1.23

N/A

NA
vs NA

Q2.23

N/A

NA
vs NA

Q3.23

N/A

NA
vs NA

Q4.23

N/A

NA
vs NA

Q1.24

N/A

NA
vs NA

Q2.24

N/A

NA
vs NA

Q3.24

N/A

NA
vs NA

Q4.24

N/A

NA
vs NA

Q1.25

N/A

NA
vs NA

Sales Growth

YoY

Current

Estimates

Q4.22

40.2K vs NA

Q1.23

31.5K vs NA

Q2.23

-1%

48.7K vs 49.4K

Q3.23

+70%

45.1K vs 26.5K

Q4.23

+4%

41.8K vs 40.2K

Q1.24

+36%

42.9K vs 31.5K

Q2.24

-20%

39.2K vs 48.7K

Q3.24

-66%

15.2K vs 45.1K

Q4.24

-72%

11.6K vs 41.8K

Q1.25

-63%

16K vs 42.9K

Return on Equity

QoQ

Q4.22

-17%

-0.17
vs -0.39

Q1.23

-5%

-0.05
vs -0.17

Q2.23

-12%

-0.12
vs -0.05

Q3.23

-2%

-0.02
vs -0.12

Q4.23

+0%

0
vs -0.02

Q1.24

-15%

-0.15
vs 0

Q2.24

-21%

-0.21
vs -0.15

Q3.24

-82%

-0.82
vs -0.21

Q4.24

-87%

-0.87
vs -0.82

Q1.25

-9%

-0.09
vs -0.87

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

NA
vs NA

Q1.23

N/A

NA
vs NA

Q2.23

N/A

NA
vs NA

Q3.23

N/A

NA
vs NA

Q4.23

N/A

NA
vs NA

Q1.24

N/A

NA
vs NA

Q2.24

N/A

NA
vs NA

Q3.24

N/A

NA
vs NA

Q4.24

N/A

NA
vs NA

Q1.25

N/A

NA
vs NA

Sales Growth

YoY

Current

Estimates

Q4.22

40.2K vs NA

Q1.23

31.5K vs NA

Q2.23

-1%

48.7K vs 49.4K

Q3.23

+70%

45.1K vs 26.5K

Q4.23

+4%

41.8K vs 40.2K

Q1.24

+36%

42.9K vs 31.5K

Q2.24

-20%

39.2K vs 48.7K

Q3.24

-66%

15.2K vs 45.1K

Q4.24

-72%

11.6K vs 41.8K

Q1.25

-63%

16K vs 42.9K

Return on Equity

QoQ

Q4.22

-17%

-0.17
vs -0.39

Q1.23

-5%

-0.05
vs -0.17

Q2.23

-12%

-0.12
vs -0.05

Q3.23

-2%

-0.02
vs -0.12

Q4.23

+0%

0
vs -0.02

Q1.24

-15%

-0.15
vs 0

Q2.24

-21%

-0.21
vs -0.15

Q3.24

-82%

-0.82
vs -0.21

Q4.24

-87%

-0.87
vs -0.82

Q1.25

-9%

-0.09
vs -0.87

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Company Description

0.00USD

N/A

10.30x

3.52x

0.0

-905.0%

$-0.0

N/A

N/A

N/A

Earnings Growth

Latest News

Latest News

Latest News

Earnings Growth

Company Description

0.00USD

N/A

N/A

N/A

N/A

10.30x

3.52x

0.0

-905.0%

$-0.0